IMMUCOR INC

Delisted

CIK 736822fmd_0B61XM8BSZYMXETZYKGFARG9YXManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jun 01, 2008 to Feb 28, 2017, 32 periods

Income Statement · Annual · Millions · USD
Line item	FY2009	FY2010	FY2011	FY2013	FY2014	FY2015	FY2016
Total revenues	301	329	333	348	388	389	380
Gross profit	216	234	237	228	248	246	236
Research and development	11	15	16	21	29	29	30
Selling, general and administrative	71	74	74	93	101	99	101
Total operating expenses	99	108	111	191	358	202	207
Operating income	117	125	126	37	(110)	43	29
Interest expense	0	0	0	91	88	89	91
Interest and investment income	2	0	1	0	0	0	0
Other non-operating income (expense)	0	(0)	5	(100)	(88)	(88)	(91)
Income before taxes	117	125	131	(64)	(198)	(45)	(62)
Income tax expense	41	43	41	(25)	(16)	16	(18)
Net income from continuing operations	76	83	89	(39)	(182)	(61)	(44)
Net income	76	83	89	(39)	(182)	(61)	(42)